Atrial fibrillation is the most common sustained cardiac arrhythmia and is associated with significantly increased mortality and morbidity. Therefore, timely diagnostic and therapeutic measures are required. The current ESC guidelines recommend regular pulse monitoring in patients with appropriate risk factors and initiation of further investigations if necessary. Treatment includes medication, interventional and lifestyle measures, and it is important to include any comorbidities.
This content is machine-translated. Please contact us if you need professional translation services.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Chronic urticaria
“Treat-to-target” approach is underpinned by new findings
- Dual GIP/GLP-1 RA in type 2 diabetes
Tirzepatide proves multiple benefits
- Pain syndrome
From pathophysiology to therapy – a reminder
- Sunscreen
Increasing risk of skin cancer due to dangerous UV radiation
- Coronary heart disease and type 2 diabetes
Relationship between baseline FFA values and all-cause mortality.
- Esophagus
Therapy of esophageal carcinoma – an overview
- Visceral Surgery Update - Part 1
Upper gastrointestinal tract and robotic visceral surgery
- Case reports: Pityriasis rubra pilaris (PRP)